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Abstract
Objectives: To describe the baseline demographic data, clinical characteristics and HIV-incidence rates of a cohort at high
risk for HIV infection in South Africa as well as the challenges experienced in establishing and maintaining the cohort.
Methodology/Principle Findings: Between August 2004 and May 2005 a cohort of HIV-uninfected women was established
for the CAPRISA 002 Acute Infection Study, a natural history study of HIV-1 subtype C infection. Volunteers were identified
through peer-outreach. The cohort was followed monthly to determine HIV infection rates and clinical presentation of early
HIV infection. Risk reduction counselling and male and female condoms were provided. After screening 775 individuals, a
cohort of 245 uninfected high-risk women was established. HIV-prevalence at screening was 59.6% (95% CI: 55.9% to 62.8%)
posing a challenge in accruing HIV-uninfected women. The majority of women (78.8%) were self-identified as sex-workers
with a median of 2 clients per day. Most women (95%) reported more than one casual sexual partner in the previous
3 months (excluding clients) and 58.8% reported condom use in their last sexual encounter. Based on laboratory testing,
62.0% had a sexually transmitted infection at baseline. During 390 person-years of follow-up, 28 infections occurred yielding
seroincidence rate of 7.2 (95% CI: 4.5 to 9.8) per 100 person-years. Despite the high mobility of this sex worker cohort
retention rate after 2 years was 86.1%. High co-morbidity created challenges for ancillary care provision, both in terms of
human and financial resources.
Conclusions/Significance: Challenges experienced were high baseline HIV-prevalence, lower than anticipated HIV-
incidence and difficulties retaining participants. Despite challenges, we have successfully accrued this cohort of HIV-
uninfected women with favourable retention, enabling us to study the natural history of HIV-1 during acute HIV-infection.
Our experiences provide lessons for others establishing similar cohorts, which will be key for advancing the vaccine and
prevention research agenda in resource-constrained settings.
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Introduction
As we move into the third decade of the AIDS epidemic, the
need to increase and improve the research being conducted in
some of the hardest hit areas of the developing world has become
increasingly clear. These regions pose unique challenges for
scientific research as they are typically resource-poor settings with
minimal existing infrastructure and populations that are not well
integrated into a formal health care system. In order to conduct
effective research into the HIV epidemic in southern Africa, it is
critical to improve our ability to maintain longitudinal cohorts in
the face of significant social, cultural, and logistical hurdles.
In order to determine which host and viral factors during the acute
and early phases of HIV-1 infection have a significant impact on the
subsequent course of disease, the Centre for the AIDS Programme of
Research in South Africa (CAPRISA) initiated the CAPRISA 002
Acute Infection Study. This study will characterize HIV-1 subtype C
viral load set point in heterosexual infection in South Africa, the role
of specific T cell immune responses in the control of replication, and
the relationship between viral set point, CD4+ T cell count trajectory
and disease progression.
The design of this study overcomes several limitations of
previous acute infection studies. While several earlier studies used
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a large window period for identification of acute infection [1–5],
others relied on patient recall of symptoms associated with acute
retroviral syndrome [6]. Still other studies focused on one
particular aspect of acute HIV infection, such as clinical signs
and symptoms [7], without placing the clinical presentation in the
context of virological and immunological responses. Furthermore,
the majority of these studies were conducted in developed
countries where both the context for the research and the viral
subtypes are markedly different from those that are found in
southern Africa and the developing world. The only prospective
acute infection study that was conducted in Africa identified acute
infections within a period averaging 1.1 months but was limited by
its focus on clinical manifestations of acute infection [8]. As a
prospective observational cohort study, this study will also provide
a methodology for setting up and managing an observational
cohort requiring frequent visits over an extended period of time
against within a very challenging, resource-constrained environ-
ment with participants who tend to be highly mobile and difficult
to contact by conventional means.
To our knowledge, this acute infection study will be the first in
southern Africa to document acute infection in a prospective
cohort with extensive follow-up on the natural history of HIV-1
subtype C infection. The aim of this paper is to provide a
preliminary description of the demographic and clinical charac-
teristics of the cohort of HIV-uninfected participants, the
challenges in administering the cohort, and some of the successful
strategies employed to overcome these obstacles. This paper
provides important information with respect to the establishment
of high-risk cohorts for acute HIV infection and other prospective
observational studies. Establishment of cohorts in developing
country setting have unique challenges which differ between
locations and populations. Our cohort consists primarily of high
risk HIV-uninfected women working as female sex workers,
recruited from a large urban area. This cohort is of high potential
impact as forms part of a larger acute infection study which
measures virological, immunological and clinical events in acute
and early infection. Results from this study are likely to provide
valuable information to inform vaccine trials, as well as
understanding host, immunological and virological correlates of
disease progression in subtype C infection. This paper provides
important information with respect to the establishment of high-
risk cohorts for acute HIV infection and other prospective
observational studies.
Materials and Methods
The CAPRISA 002 Acute Infection Study is being conducted at
the Doris Duke Medical Research Institute (DDMRI) at the
Nelson R Mandela School of Medicine of the University of
KwaZulu-Natal in Durban, South Africa. The goal of this study is
to identify acute HIV infection and, by prospectively following
participants with acute infection, provide thorough information on
the natural history of HIV-1 subtype C infection.
Cohort Development
Building on participatory research methods developed for
earlier work in similar cohorts [9–11], a network of ten
community liaison persons (CLPs) was established prior to
initiation of the study to assist with study recruitment and
retention efforts. Recruitment was based upon word-of-mouth
and site visits by the CLPs. Initially we recruited directly within
5 kilometres of the clinic site, but CLPs did bring women in
from as far as around 45 kilometres (approximately 3 to 28
miles). Most of the recruitment sites were associated with
transport links into the city, and so participants were able to
access the existing system of public transport. Participants
received reimbursement for time, effort and their transport
expenses when they visited the clinic. We limited our
recruitment radius so that no woman would have to use her
own money. Women from the community who were at least
18 years old and either self-identified as female sex workers
(FSWs) or reported having had at least three partners in the
3 months prior to recruitment were screened for participation in
the study. Young women in urban South Africa are already at
high risk for HIV infection [12], and our goal was to identify
women who would theoretically be at the greatest risk of HIV
acquisition. Women who were pregnant at the time of screening
or who planned to travel away from the study site for more than
3 months were excluded from participation.
The screening procedure for identifying HIV-negative women
consisted of voluntary counselling and testing (VCT) followed by a
blood collection for rapid HIV antibody testing and urine
collection for pregnancy testing. If the first antibody test
(Determine: Abbott Laboratories, Tokyo, Japan) was negative,
the participant was enrolled into the HIV-negative cohort. If the
first antibody test was positive, a second rapid antibody test
(Capillus; Trinity Biotech, Jamestown, NY, USA) was adminis-
tered. Those with a two positive antibody tests were referred for
HIV follow-up care. Those with discordant antibody results were
given a confirmatory HIV enzyme immunoassay (EIA) (BEP 2000;
Dade Behring, Marburg, Germany) and were either enrolled into
the HIV-negative cohort or referred for HIV follow-up care on the
basis of those results.
In order to maximize participant retention, the study visit
schedule was thoroughly explained during the informed consent
process and was re-emphasized at each study visit. Detailed locator
information was collected and was reviewed at each subsequent
visit and a secure participant-tracking database was established to
facilitate visit scheduling and prompt follow-up for missed visits.
Additionally, participants were compensated (100 South African
Rand, ,$14USD, as approved by the ethics committee) for their
transport to the study site and for their time at the clinic.
To improve communication with the cohort, a web-based short
message service (SMS) is used to send pre-approved cell phone text
messages to willing participants. This system is used to remind
participants who generally do not have access to fixed-line
telephone services about their study appointments. The service is
cost effective (0.33 South African Rand per message) and also
provides an electronic record of all messages sent and whether or
not they are received.
If a participant misses a visit, the clinic nurse administrator
attempts to call a participant for the first 3 days after the clinic
visit. A SMS with the clinic contact number is also sent out on the
second and third days. If these attempts at contact are unsuccessful
by the second week, the study community liaison officer attempts
person-to-person contact by travelling to the participant’s
documented contact site as well as to the site from which the
participant was originally recruited.
In addition to the methods above, the study staff and
community liaisons regularly communicate with the study
community at large to increase awareness of HIV/AIDS and
explain the purpose of HIV prevention research and the
importance of completing research study visits. A Community
Research Support Group (CRSG) comprised of the CLPs meets
bi-monthly with study representatives to discuss and provide
feedback on the progress of the study and to discuss challenges
faced by the study team with regards to community and
participant relations.
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Participant Protection
The study protocol and informed consent documents were
reviewed by the local ethics committees of the University of
KwaZulu-Natal, the University of Cape Town, the University of
the Witwatersrand in Johannesburg, and by the Prevention
Sciences Review Committee (PSRC) of the Division of AIDS
(DAIDS, National Institutes of Health, U.S.A.). The consent forms
were translated into isiZulu and written informed consent is
obtained at each stage of the study (screening, enrolment into
HIV-negative cohort, enrolment into acute infection phase, and
for sample storage). All women screened for participation, whether
ultimately enrolled into the study cohort or not, receive HIV pre-
and post-test counselling, risk reduction counselling, male and
female condoms, access to clinical care, and treatment for sexually
transmitted infections (STIs). HIV/STI risk reduction counselling,
condom provision, and prevention education supplies are
administered at each subsequent study visit. One-on-one counsel-
ling was provided by a non-governmental organization which
offered the same service in the public sector in the region, to be
consistent with the services in the region. Overcoming one of the
key challenges to doing HIV-related work in this context [11],
participants who were HIV infected during the study were referred
to the CAPRISA Antiretroviral Treatment (CAT) programme
where they were offered ongoing care, and treatment for HIV
when clinically eligible.
Study Visits and Procedures
Once enrolled into the HIV-negative observational cohort, the
participants underwent a baseline evaluation that included: a HIV
behaviour risk assessment, a clinical evaluation, blood collection
for routine laboratory assessment and HIV status, and a specimen
collection for sexually transmitted infection (STI) diagnosis.
Following the baseline evaluation, participants in the HIV-
negative cohort attend monthly follow-up evaluations for a
maximum of 24 months. The monthly evaluations consist of a
clinical evaluation, two HIV antibody rapid tests, HIV EIA, and
pooled HIV-1 RNA testing (Amplicor v1.5: Roche Diagnostics,
Rotkreuz, Switzerland). A urine dipstick is done on clinical
suspicion of pregnancy, or if requested by the participant. In
addition, a routine laboratory assessment, urinalysis, and STI
screening are performed at 6-monthly intervals.
Women from the HIV-negative cohort are diagnosed with acute
HIV infection by (1) the detection of HIV-1 antibodies within
5 months of a previously negative HIV-1 test; or (2) evidence of
HIV-1 viral replication in the absence of HIV-1 antibodies. While
women in this cohort were screened monthly allowing for rapid
identification of acute infection, a 5 months window period was
allowed to enable to recruit from other prevention cohorts where
follow-up was only quarterly. Time of infection is defined as the
mid-point between the last HIV antibody negative test and the first
HIV antibody positive test; or if a positive RNA PCR assay is
available on the same date as a negative HIV EIA, the date of
HIV infection is estimated at 14 days prior to the first positive
RNA PCR assay.
Staff Training and Infrastructure Development
Given the extended scope and longitudinal nature of this study,
CAPRISA was required to expand the size of the staff and the
ability of the organization to manage a large cohort. After hiring
additional clinicians, nurses, counsellors, and laboratory person-
nel, all team members underwent extensive training in both good
clinical practice (GCP) and in the particulars of this study with
respect to the case report forms (CRFs) for documentation, the
quality control plan, and Human Subjects Protections (HSP).
Furthermore, the capacity of the laboratory had to be increased to
handle the large quantity of specimens related to the study.
Data Management and Statistical Analysis
All data is entered onto case report forms (CRFs) at the study
sites and faxed into the CAPRISA Data Management Centre,
using the DataFax system (Clinical DataFax Systems Inc.,
Ontario, Canada). This capability did not previously exist at site,
and had to be implemented in order to collect the data for this
study. Source documents and original CRFs are maintained on
site while an electronic version of the CRF is maintained by the
Data Management Centre. Quality assurance and quality control
are maintained and checked at specified intervals. All analyses are
conducted using the SAS statistical package version 9.1 (SAS
Institute, Cary, NC, U.S.A.).
Results
Establishing the Cohort
Between August 2004 and May 2005, 775 women who were
classified as high-risk either by self-identification as sex workers or
self-report of more than three sexual partners in the previous
3 months were screened for participation in the observational
cohort. Recruitment was done at known FSW sites in the city,
therefore the majority of these women (n= 193, 78.8%) were self-
identified as sex workers. The cumulative number of women
screened and enrolled over the entire 10-month period can be seen
in Figure 1.
Of the 775 women screened, 59.6% (95% CI 55.9%–62.8%)
were found to be HIV-positive. The mean ages of the women who
were screened and found to be HIV-positive and HIV negative
were 29.3 years (range 16–58) and 34.2 years (range 18–58),
respectively (p,0.001). The HIV prevalence among the screening
participants changed dramatically over time from 83% in the first
month of screening to 17% in the last month of screening
(Figure 2).
Of the 313 women who were HIV-negative, 245 HIV-negative
women were eligible and agreed to participate in the HIV-
negative cohort. Exclusion criteria for women who were
uninfected at screening were as follows: less than three sexual
partners in the previous 3 months (n = 22), women who were
pregnant at the time of screening (n= 16), women who planned to
relocate (n = 4), women younger than 18 years (n = 3), and women
Figure 1. Cumulative HIV serostatus of screening participants
over time.
doi:10.1371/journal.pone.0001954.g001
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who were afraid of the testing procedures (n = 2). There were
twenty-one women who were eligible following screening but
never returned for enrolment into the HIV-negative cohort.
The demographic characteristics of the 245 women enrolled in
the HIV-negative cohort are presented in Table 1. The mean age
of the overall cohort was 34.3 years (range 18–58). Approximately
42.0% of the cohort had 11 or 12 years of education or higher,
33.5% had between 8 and 10 years of education, and 24.5% had
an education level less than 8 years.
The numbers of steady and casual partners reported by the
women are listed in Table 2. Steady partners were defined as
someone seen ‘‘most of the time, often over a period of time’’ while
a casual partner was someone the women saw only occasionally or
even only once (but not a client in the case of the FSWs).
All of the women in the cohort have engaged in peno-vaginal
intercourse; 34.6% and 25.4% of the cohort have engaged in anal
and oral sex respectively. The mean age at sexual debut was
17 years (range 12–26) and at the time of study enrolment the
mean number of days since last sexual contact was 4.8 (range 1–
45). While 58.8% of participants indicated that a condom was used
at last sexual encounter, 13.9% and 34.3% of the women indicated
that they were never able to insist on a condom being used with
casual and steady partners respectively (Table 3). Additionally, a
high proportion of the women (75.7%) provided economic support
to adults (mean 0.9, range 0–7) or children (mean 2.8, range 0–14).
Among the women who self-identified as FSWs, the median
length of sex work was 3 years (range 1 month–31 years) and the
median age at which the women began sex work was 26 years
Figure 2. HIV prevalence in participants screened for enroll-
ment into Phase I of the study over time, both cumulative and
per month.
doi:10.1371/journal.pone.0001954.g002
Table 1. Demographic characteristics of the HIV-negative observational cohort.
Number (N=245) Percent Number (N=244) Percent
Race/ethnicity Marital status
Black 241 98.4 Single, no steady partner 10 4.1
White 3 1.2 Married 16 6.5
Indian 1 0.4 Divorced 3 1.2
Widowed 3 1.2
Education Stable partner 75 30.6
. Grade 11 103 42.0 Multiple partners 135 55.1
Grade 8–10 82 33.5 Separated 2 0.8
, Grade 8 60 24.5
(Note: where women refused to answer certain questions, the category total is less than the cohort total of 245.)
doi:10.1371/journal.pone.0001954.t001
Table 2. Sexual partner history for the 245 women in the HIV-negative observational cohort.
Partners in the previous 3 months Lifetime partners
Steady Casual Steady Casual
# of partners reported Number Percent Number Percent Number Percent Number Percent
0 7 2.9 4 1.7 2 0.8 0 0
1 158 65.6 14 5.9 9 3.7 0 0
2–3 62 25.7 166 69.5 42 17.4 32 13.4
4–6 8 3.3 33 13.8 80 33.1 31 13.0
7–12 1 0.4 3 1.3 20 8.3 17 7.1
.12 0 0 0 0 7 2.9 2 0.8
Too many to remember 5 2.1 19 7.9 82 33.9 156 65.5
Total 241 100 239 100 242 100 238 100
(Note: where women refused to answer certain questions, the category total is less than the cohort total of 245.)
doi:10.1371/journal.pone.0001954.t002
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(range 14–53 years). The median number of days performing sex
work per week was 3 days (range 1–7 days) with a median of 2
clients see per day (range 1–10), with a median of 2 clients (range
0–30) seen in the previous week.
Maintaining the Cohort
Enrolment for the Phase 1 HIV-negative cohort began in
September 2004 and the last participant was terminated in May
2007. The retention rate for the HIV-negative cohort was 86.1%.
Despite the high mobility and low socioeconomic status of this
population, only 13 (5.3%) of the HIV-negative cohort were
terminated because they could not be traced. Other reasons for
termination included participant relocation (n= 13), inability to
adhere to the study schedule (n = 4), participant withdrew consent
(n = 4), and death due to causes unrelated to study participation
(n = 5).
As part of the study protocol, the women in the cohort received
regular clinical examinations. Key baseline characteristics are
summarized in Table 4. On enrolment into the cohort, the HIV-
negative cohort had a mean body mass index (BMI) of 31.0 kg/
m2. Of the 245 participants, 121 (49.4%) had a BMI greater than
30 kg/m2 (defined as obese) and a further 58 (23.7%) were
overweight with a BMI between 25 and 30 kg/m2. Sixty-two
participants (25.3%) had a normal BMI between 18.5 and 25 kg/
m2 and only five participants (2.0%) were underweight with a BMI
less than 18.5 kg/m2. Despite the high prevalence of obesity in this
cohort, hypertension was not common. The mean systolic blood
pressure was 117 mmHg and the mean diastolic pressure was
76 mmHg. Only 29 (11.8%) of the women had a systolic pressure
greater than 140 mmHg or a diastolic pressure greater than
90 mmHg. Moderate anaemia was relatively common in this
population and 48 (19.7%) of the women had a haemoglobin less
than 12 g/dL at study enrolment.
On enrolment into the cohort and at 6-monthly intervals, these
women underwent STI screenings for Trichomonas vaginalis, Neisseria
gonorrheae, Chlamydia trachomatis, Mycoplasma genitalium, syphilis, and
Herpes simplex virus-2. Overall, 29.4% of women were infected
with an STI at baseline. This percentage increases to 62.0% if
bacterial vaginosis is included. Further, while none of the women
were pregnant on enrolment, there were 32 pregnancies in the
cohort for an incidence of 8.5 per 100 person-years (95% CI 5.6–
11.5). During this same period, there have been 5 deaths unrelated
to study participation. Causes of death include: stab wound (1),
clinically reported as idiopathic thrombocytopenia (1), and
unknown (3).
Finally, after 4784 monthly visits by 245 participants in this
HIV-negative cohort, we identified 28 acute HIV infections.
Twenty of the acute infections were among women who had self-
identified as female sex workers and 8 of the acute infections were
among women who had reported more than three partners in the
preceding 3 months. The annual seroincidence after 390 person
years was 7.2 per 100 person-years (95% CI 4.5–9.8).
We investigated if the number of new HIV infections reduced
over time, which could be due to women who were most at risk of
getting infected seroconverting early during follow-up or women
reducing their risky behaviour over time and in response to
repeated risk-reduction counselling. There was a significant trend
over time in the rate at which women seroconverted (p-
value = 0.0283), and this is graphically illustrated in Figure 3.
Discussion
This paper describes the recruiting strategies, screening
methods, enrolment procedures and retention techniques for a
cohort of high-risk South African women, consisting largely urban
female sex workers, a typically transient and mobile population
that formed the basis for the CAPRISA 002 Acute HIV Infection
study. We encountered numerous challenges over the course of
establishing and administering the cohort and this paper aims to
describe our strategies for overcoming these challenges.
The first challenge was defining the inclusion and exclusion
criteria for the cohort. The study design called for uninfected yet
‘‘high risk’’ women so that we could theoretically maximize the
number of acute infections we were able to identify. As we began
Table 3. Ease of condom use with casual and steady partners,
showing a trend towards ease of condom use with casual
partners, and lower and inconsistent condom use with steady
partners (Fisher’s exact test; p,0.001).
Ease of Condom Use Casual (% and n) Steady (% and n)
Never 13.9% (34) 34.3% (84)
Sometimes 32.2% (79) 43.3% (106)
Every Time 53.9% (132) 20.4% (50)
doi:10.1371/journal.pone.0001954.t003
Table 4. Baseline medical characteristics of the HIV-negative
cohort (n = 245).
Mean (SD) Range
Blood pressure (mmHg)
Systolic 117 (15) 90–200
Diastolic 76 (10) 55–110
Body mass index (kg/m2) 31.0 (7.8) 17.2–54.5
Hemoglobin (g/dL) 12.7 (1.3) 7.7–16.1
Hematocrit (%) 37.3 (0.3) 25–46
doi:10.1371/journal.pone.0001954.t004
Figure 3. Percentage of acute HIV infections as a function of
time in follow up (in days), showing a decrease in acute
infections over time of follow up for the study.
doi:10.1371/journal.pone.0001954.g003
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recruitment, we were confronted with cultural and social barriers
to delineations within this population. While many women were
involved in transactional sex of some form, they were often
reluctant to identify themselves as FSWs. Transactional sex for
money or goods with non-regular partners is common in this
region and is often not explicitly described as commercial sex work
[13]. Once these cultural taboos became apparent, our study staff
made a concerted effort to ensure that transactional sex was asked
about in an open and permissive manner. Close work with the
CLPs, some of whom were self-identified FSWs, enabled the
research team to systematize a non-judgmental approach. Future
work in similar cohorts needs to take account of the fact that terms
such as ‘sex worker’ or ‘client’ may be inappropriate, and that
broader definitions that include multiple partners who provide
material needs in exchange for sex should be included in
behavioural risk assessments.
The screening was made more difficult because of the high
prevalence of HIV (59.6%) in the screening population. This is an
extremely high prevalence rate, even when compared with the
reported prevalence rates of 13.3% for South African women,
16.5% for the highly-burdened KwaZulu-Natal province, and
33.3% for South African women between the ages of 25 and
29 years [14]. The change in HIV prevalence rates over the
course of screening was quite dramatic – from 83% to 17% – with
the majority of uninfected participants identified in the final
quarter of recruitment. The decline in prevalence over the course
of screening could reflect a desire of women who were most
concerned about their status to come first to the clinic for HIV
testing, or for women who were most active in sex work to come
forward first. Regardless, this discrepancy highlights the fact that
cross-sectional surveys of seroprevalence can be a highly variable,
or even unreliable, indicator of true prevalence and underscores
the benefits of having an extended screening period with adequate
numbers of screening participants. Enrolling participants over
time from different populations with different risk profiles could
bias the results of many studies. This variation is particularly
significant for prevention studies where care should be taken to
design the randomization process to equally distribute these
differences with respect to time and intervention. For example, it is
important to use blocked randomization to ensure that equal
numbers of participants are enrolled at each stage of the trial into
the different treatment arms. Accordingly, any trends over time in
these studies must be interpreted with caution as these trends could
be due to baseline differences in the participants.
In our study there was a significant age difference between the
HIV-positive women who were screened (mean 29.3 years) and
the HIV-negative women (mean 34.3 years) who were enrolled
into the study cohort. This difference may be a sign of the
changing demographics of the HIV epidemic among high-risk
women in South Africa and supports the view that the epidemic is
being most acutely experienced by younger South African women.
On the other hand, lower HIV infection susceptibility, potentially
(but controversially) associated with factors such as HLA alleles,
partner-specific alloimmunity, reduced CD4+ T cell susceptibility,
variability of cellular proteins involved in HIV-1 replication, host
antiviral cellular proteins, or some related host genetic factor [15–
23], may explain why some of the women have remained negative
despite high-risk exposures and therefore remain uninfected
although significantly older. That is, the women who are
susceptible to infection are infected at an early age, leaving the
less susceptible women as the core of the HIV-negative cohort.
This trend is also supported by our finding that women who
remain the in cohort are statistically less likely to seroconvert as
follow-up progresses. Further research has been initiated to
examine some of these factors in the HIV-negative, high-risk
women that remain uninfected at the end of their study follow-up.
Another major challenge of working with this cohort of HIV-1
negative women has been to reconcile the study goals of
identifying acute infections with the ethical imperative to
aggressively promote prevention. Prevention efforts in this cohort
included the provision of male and female condoms along with
monthly HIV risk-reduction counselling. In spite of these efforts,
the high rate of pregnancies and STIs in this cohort underscores
the difficulty of prevention promotion in this population. Similar
to vaccine or microbicide studies that intensively promote
prevention, our experience is that some women will remain at
risk for HIV infection in spite of the best efforts of the research
team.
Retention rates for the HIV-negative observational cohort have
been extremely successful with close to 86% retention over the
duration of follow-up. Given the highly mobile nature of this
population, these rates are high and bode well for future
microbicide and vaccine studies which could have even greater
retention rates in light of the perceived benefits of the intervention
to the participants. We believe that this success underscores the
value of having a dedicated network of community liaisons and of
making a coherent and concerted effort to engage the community
on a structural level. Making use of all available contact
mechanisms and channels, especially the cell phones and short
message system technology, proved to be essential for maintaining
follow-up in this highly mobile cohort in which fixed-line
telecommunications access is not common. We have established
the feasibility and utility of using these services to both remind
patients about their study visits and to follow up with missed visits.
Additionally, while the study’s CLP network was initially
intended as an additional measure to assist with participant
tracking and retention, we found that the designated CLPs were
ultimately only effective in tracing women with whom they had
pre-existing relationship or acquaintance. As the study progressed,
the study staff would increasingly rely on friends and relatives to
relay messages to participants. Other factors that have undoubt-
edly contributed to the high retention rates include the monetary
compensation for study visits, the regular counselling sessions and
subsequent relationships formed with the counsellors, the
distribution of condoms, and the knowledge that participants will
be referred for STI treatment and other medical services as
necessary.
We have also presented here an overview of the demographic,
behavioural, and clinical characteristics of this cohort. In
reviewing the clinical profile of these women, while they are a
relatively young population and would thought to be healthy, they
have a number of comorbidities. The rates of hypertension
(11.8%) are lower than reported rates for South Africa of 21.1%
[24] but the cohort tended to be overweight or obese with a
relatively high prevalence of anemia. The presence of these
comorbidities will be important for the clinical management of
these women and will need to be considered among HIV-infected
South African women. They also have high rates of STIs and
pregnancy despite intensive counselling and ready availability of
prevention materials. Lastly, the non-study related deaths of five of
the participants reveals that even HIV-uninfected women living in
urban South Africa are at high-risk of death. As we continue to
accrue longitudinal data on this cohort, we anticipate that these
baseline characteristics will be expanded on, and specific results on
anaemia during acute infection have been published [25].
The behavioural data provides an overview of the sexual history
and potential exposures of this theoretically high-risk cohort,
particularly the FSWs. A previous survey of sex workers in the
CAPRISA 002 Study
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KwaZulu-Natal province of South Africa found that women
working at truck stops averaged 22 sex acts per week, with coitus
occurring between two to ten times in a 24 hour period [9]. This
earlier survey also found that peno-vaginal sex was the only
practice reported, with strong cultural sanctions against anal and
oral sex. The sex workers in this urban cohort appear to have
customers with whom they engage in fewer acts but see more
regularly, averaging just three clients per week, and are also
engaging in anal and oral sex. Consequently, they have a very
different risk profile than what had been anticipated based on the
prior studies. This difference in risk behaviour has likely impacted
the HIV seroincidence in this cohort. Data are being analysed to
determine the specific behavioural risk factors for HIV infection in
this cohort.
The perceived ease of condom use in this cohort shows that
women are significantly more likely to feel that they will be able to
use condoms with casual partners than with their steady partners.
This difference may explain why condom use has not led to a
reduction in HIV risk as these women are still vulnerable due to
inconsistent condom use with their steady partners. This
observation suggests that condom use may be associated with
perceptions of trust; whatever the case, condom use is inconsistent
at best in this population. The behavioural risk data collected at
baseline will be analysed after the full 24 month follow-up period
to see which factors are most predictive of HIV acquisition in this
cohort.
Based on previous data, the projected annual sero-incidence for
this high-risk population was 18.2% [9,12]. The actual seroinci-
dence in this cohort has been 7.2% which is a little higher than the
national seroincidence estimates of 6.3% for all South African
women between the ages of 15 and 49 [14]. The risk of HIV
acquisition in the context of the maturing South African HIV
epidemic seems to be highly generalized. Hence, our designations
of ‘‘high risk’’ are seemingly less relevant in retrospect and perhaps
need not be considered as rigorously when designing future
studies. Furthermore, unmeasured susceptibility factors may have
disproportionately influenced the observed infection rate in this
cohort of highly exposed individuals, where the women who were
more susceptible had acquired HIV prior to screening for this
study. Furthermore, our data support the notion that high-risk
cohorts may yield fewer seroconversions over time, and that this
attrition should be factored into the design of such cohorts.
Women who remain in the cohort at the end of the follow-up, may
represent a group enriched with host genetic resistance factors,
and this is currently being explored as this group of woman has
been recruited into a highly exposed persistently negative cohort
for additional study.
Conclusion and Significance
To the best of our knowledge, this is the first prospective cohort
to be assembled in southern Africa for a comprehensive analysis of
the behavioural, clinical, and immunological characteristics
associated with acute HIV infection. The methods, as well the
challenges, of recruiting and successfully retaining a HIV-negative
cohort have been described and can provide guidance for others
wanting to assemble similar cohorts. Given the characteristics of
our cohort, these experiences are particularly relevant to the
recruitment and retention of cohorts of urban female sex workers
in South Africa for HIV prevention and pathogenesis research.
The changing nature of the epidemic must be considered when
recruiting high risk HIV-negative cohorts in prevention research,
as demonstrated by the lower than anticipated seroincidence in
this study.
Understanding natural history of HIV infection from as early a
point following exposure to HIV as possible is key for the design,
development and targeting of new prevention interventions as well
as for the treatment of advancing HIV disease. Understanding
how to identify those most at risk for HIV infection, whether this is
due to high-risk behaviours, or due to the increased risk of
infection due to high viral loads during acute or recent infection,
or due to the increases risk conferred by concomitant sexually
transmitted infections, has recently been suggested as the key
concern for prevention science [26]. It is hoped that data from the
Acute Infection study will contribute significantly to vaccine
development by describing the natural history of HIV infection,
the impact of host and viral factors during acute infection on viral
load set point, as well as the impact of viral set-point on disease
progression. Behavioural data collected before and after acute
infection should assist in developing algorithms to identify those
most at risk of infection. HIV screening algorithms [27] and
clinical data collected during acute infection are potentially fruitful
explorations of efficient and effective screening algorithms for
identifying acute infection. These specific research areas will be
addressed separately in publications from the CAPRISA 002
Acute Infection Study Team.
Acknowledgments
We would like to acknowledge the co-operation and assistance of Prof Gita
Ramjee and her team at the Medical Research Council of South Africa,
HIV Prevention Research Unit. The significant contribution of our
community research group and community liaison persons to our
recruitment and retention is acknowledged. We thank our participants
who make a significant personal contribution in HIV prevention research
through their continued support and participation in our work.
Ethics: The Acute Infection study was reviewed and approved by the
research ethics committees of the University of KwaZulu-Natal (E013/04),
the University of Cape Town (025/2004), and the University of the
Witwatersrand (MM040202). All participants provided written informed
consent for screening, enrolment and specimen storage.
Author Contributions
Conceived and designed the experiments: LM CW CG SAK KM Fv QA.
Performed the experiments: LM CW CG KM Fv II. Analyzed the data:
AG. Wrote the paper: LM CW CG SAK KM Fv SA AG NB QA. Other:
Conceptualized the paper and drove the paper writing and revision
process: Fv. Study coordinator and behavioural co-investigator on the
Acute Infection Study: Fv. Protocol co-Chair and clinical co-investigator:
KM. Assisted in the conceptualization of the paper: AG KM. Commented
on succeeding drafts of the paper: AG NB KM II CW LM CG SAK QA.
Protocol co-Chair and virology co-investigator: CW. A Research fellow at
CAPRISA: SA. Prepared the initial drafts of the paper, conducted the
literature review, and assisted with subsequent redrafting of the paper: SA.
An immunology co-investigator on the study: LM CG. Head of the
laboratory core: LM. The study epidemiologist and a co-investigator: QA
SAK. The study statistician: AG. Conducted the statistical analyses and
produced the graphs for the paper: AG. The study community liaison
officer and co-investigator: NB. Contributed the sections dealing with
community: NB. The study clinician: II. Collected the clinical data for the
study: II.
References
1. Costello C, Nelson KE, Suriyanon V, Sennun S, Tovanabutra S, et al. (2005)
HIV-1 subtype E progression among northern Thai couples: traditional and
non-traditional predictors of survival. Int J Epidemiol 34: 577–584.
2. Deschamps MM, Fitzgerald DW, Pape JW, Johnson WD Jr. (2000) HIV
infection in Haiti: natural history and disease progression. AIDS 14:
2515–2521.
CAPRISA 002 Study
PLoS ONE | www.plosone.org 7 April 2008 | Volume 3 | Issue 4 | e1954
3. Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, et al. (2002) Use of
laboratory tests and clinical symptoms for identification of primary HIV
infection. AIDS 16: 1119–1129.
4. Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, et al. (2000) Natural
history of human immunodeficiency virus type 1 viremia after seroconversion
and proximal to AIDS in a large cohort of homosexual men. J Infect Dis 181:
872–880.
5. Saah AJ, Hoover DR, Weng S, Carrington M, Mellors J, et al. (1998)
Association of HLA profiles with early plasma viral load, CD4+ cell count and
rate of progression to AIDS following acute HIV-1 infection. AIDS 12:
2107–2113.
6. Vanhems P, Voirin N, Hirschel B, Cooper DA, Vizzard J, et al. (2003)
Incubation and duration of specific symptoms at acute retroviral syndrome as
independent predictors of progression to AIDS. J Acquir Immune Defic Syndr
32: 542–544.
7. Bollinger RC, Brookmeyer RS, Mehendale SM, Paranjape RS, Shepherd ME,
et al. (1997) Risk factors and clinical presentation of acute primary HIV infection
in India. JAMA 278: 2085–2089.
8. Lavreys L, Thompson ML, Martin HL Jr., Mandaliya K, Ndinya-Achola JO, et
al. (2000) Primary human immunodeficiency virus type 1 infection: clinical
manifestations among women in Mombasa, Kenya. Clin Infect Dis 30: 486–490.
9. Abdool Karim Q, Abdool Karim SS, Soldan K, Zondi M (1995) Reducing the
risk of HIV infection among South African Sex Workers: Socioeconomic and
Gender Barriers. Am J Public Health 85: 1521–1525.
10. Ramjee G, Karim SS, Sturm AW (1998) Sexually transmitted infections among
sex workers in KwaZulu-Natal, South Africa. Sex Transm Dis 25: 346–349.
11. Ramjee G, Morar NS, Alary M, Mukenge-Tshibaka L, Vuylsteke B, et al. (2000)
Challenges in the conduct of vaginal microbicide effectiveness trials in the
developing world. AIDS 14: 2553–2557.
12. Gouws E (2005) HIV Incidence Rates in South Africa. In: Abdool Karim S,
Abdool Karim Q, eds. HIV/AIDS in South Africa. New York: Cambridge
University Press. pp 67–76.
13. Dunkle KL, Jewkes RK, Brown HC, Gray GE, McIntryre JA, et al. (2004)
Transactional sex among women in Soweto, South Africa: prevalence, risk
factors and association with HIV infection. Soc Sci Med 59: 1581–1592.
14. Shisana O, Rehle T, Simbayi LC, Parker W, Zuma K, et al. (2005) South
African National HIV Prevalence, HIV Incidence, Behaviour and Communi-
cation Survey, 2005. Cape Town: HSRC Press. pp 33–50.
15. Allen TM, Altfeld M, Geer SC, Kalife ET, Moore C, et al. (2005) Selective
escape from CD8+ T-cell responses represents a major driving force of human
immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals
constraints on HIV-1 evolution. J Virol 79: 13239–13249.
16. Begaud E, Chartier L, Marechal V, Ipero J, Leal J, et al. (2006) Reduced CD4 T
cell activation and in vitro susceptibility to HIV-1 infection in exposed
uninfected Central Africans. Retrovirology 3: 35.
17. Fowke KR, Dong T, Rowland-Jones SL, Oyugi J, Rutherford WJ, et al. (1998)
HIV type 1 resistance in Kenyan sex workers is not associated with altered
cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine
production. AIDS Res Hum Retroviruses 14: 1521–1530.
18. Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, et al. (2004)
Dominant influence of HLA-B in mediating the potential co-evolution of HIV
and HLA. Nature 432: 769–775.
19. Martin G, Tremblay MJ (2004) HLA-DR, ICAM-1, CD40, CD40L, and CD86
are incorporated to a similar degree into clinical human immunodeficiency virus
type 1 variants expanded in natural reservoirs such as peripheral blood
mononuclear cells and human lymphoid tissue cultured ex vivo. Clin Immunol
111: 275–285.
20. Paxton WA, Martin SR, Tse D, O’Brien TR, Skurnick J, et al. (1996) Relative
resistance to HIV-1 infection of CD4 lymphocytes from persons who remain
uninfected despite multiple high-risk sexual exposure. Nat Med 2: 412–417.
21. Rowland-Jones SL, Dong T, Fowke KR, Kimani J, Krausa P, et al. (1998)
Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant
prostitutes in Nairobi. J Clin Invest 102: 1758–1765.
22. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, et al. (2004) The
cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old
World monkeys. Nature 427: 848–853.
23. Truong LX, Luong TT, Scott-Algara D, Versmisse P, David A, et al. (2003)
CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed
uninfected intravascular drug users in Vietnam. AIDS 17: 1425–1434.
24. Steyn K, Gaziano TA, Bradshaw D, Laubscher R, Fourie J (2001) Hypertension
in South African adults: results from the demographic and health survey, 1998.
J Hypertens 19: 1717–1725.
25. Mlisana K, Auld SC, Grobler A, van Loggerenberg F, Williamson C, et al.
(2008) Anaemia in Acute HIV-1 Subtype C Infection. PLoS ONE 3: e1626.
26. West GR, Corneli AL, Best K, Kurkjian KM, Cates W Jr. (2007) Focusing HIV
prevention on those most likely to transmit the virus. AIDS Educ Prev 19:
275–288.
27. Abdool Karim SS, Mlisana K, Kharsany AB, Williamson C, Baxter C, et al.
(2007) Utilizing nucleic acid amplification to identify acute HIV infection. AIDS
21: 653–655.
CAPRISA 002 Study
PLoS ONE | www.plosone.org 8 April 2008 | Volume 3 | Issue 4 | e1954
